Gene Therapy Analytical Development Summit

Gene Therapy Analytical Development Summit is organized by Hanson Wade and will be held from Nov 19 - 21, 2019 at The Westin Copley Place, Boston, Boston, Massachusetts, United States of America.

Description:
In the context of unprecedented gene therapy clinical progress and mounting regulatory scrutiny, the inaugural Gene Therapy Analytical Development Summit will unite large pharma and innovative biotechs to develop robust analytical tools to guarantee the consistency, quality and safety of gene therapy products.

Focused specifically on addressing the unique analytical challenges posed by gene therapy vectors, this technical scientific meeting will unite the ‘boots on the ground’ scientists grappling with these challenges first-hand.

Delving into technical analytics to assess potency, capsid integrity, empty vs full capsids and viral titers of AAV and lentiviral vectors, this is your opportunity to enhance your existing analytical methods and explore innovative novel tools to support safe and effective gene therapy development.

 Pre-Conference Workshops:
Workshop A
Date: Tuesday, November 19
Time: 8:00 am - 11:00 am
Enhancing Analytical Comparability Strategies to Support Every Stage of Development
Whatever stage of development you’re currently at, progressing to the next phase and adapting your analytical strategy is a key challenge you will need to navigate. This is all in the context of increasing regulatory scrutiny and uncertainty over the analytical and comparability strategies required to satisfy the regulators.

Workshop B
Tuesday, November 19
11:30 am - 2:30 pm
Discussing How to Develop Accurate Assays to Measure Residual Impurities 
Analyzing both DNA and protein impurities is a key aspect of gene therapy analytical investigation. It’s clear that there are numerous challenges involved in this analysis, that limit the potential to establish methods that capture the extent and diversity of impurities present.

Workshop C
Tuesday, November 19
3:00 pm - 6:00 pm
Investigating Outsourcing Strategies to Utilize Internal and External Resources Effectively 
Establishing mutually beneficial collaborations with external organizations is a key factor in long-term success. Given the complexity of gene therapy analytics, establishing these relationships is a complex task and decisions around when as well as what to outsource are key. This workshop will provide an opportunity for in-depth discussions from those who have been intimately involved in this aspect of this field.